Antimicrobial Consumption in England, 2017 to 2021

The UK’s 5-year National Action Plan for Antimicrobial Resistance has an ambition to reduce total antimicrobial consumption, a key driver of antimicrobial resistance, in humans by 15% by 2024, highlighting the need for active surveillance to inform on progression. The English Surveillance Programme...

Full description

Bibliographic Details
Published in:Medical Sciences Forum
Main Authors: Sabine Bou-Antoun, Angela Falola, Holly Fountain, Hanna Squire, Colin S. Brown, Susan Hopkins, Sarah M. Gerver, Alicia Demirjian
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Subjects:
antimicrobial consumption
antibiotic
antifungal
England
Online Access:https://www.mdpi.com/2673-9992/15/1/1
Description
Summary:The UK’s 5-year National Action Plan for Antimicrobial Resistance has an ambition to reduce total antimicrobial consumption, a key driver of antimicrobial resistance, in humans by 15% by 2024, highlighting the need for active surveillance to inform on progression. The English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) report, Chapter 3, commentates on key national antimicrobial consumption trends, across primary and secondary care in England, between 2017 to 2021. These findings were presented at the ESPAUR Report webinar on 23 November 2022.
ISSN:2673-9992

Similar Items